KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Net Cash Flow: 2010-2025

Historic Net Cash Flow for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to -$21.6 million.

  • Emergent BioSolutions' Net Cash Flow fell 125.29% to -$21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.7 million, marking a year-over-year increase of 32.24%. This contributed to the annual value of -$6.1 million for FY2024, which is 98.85% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Net Cash Flow of -$21.6 million as of Q3 2025, which was down 118.43% from $117.2 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Net Cash Flow peaked at $400.5 million during Q4 2022, and registered a low of -$343.6 million during Q2 2023.
  • Moreover, its 3-year median value for Net Cash Flow was -$8.0 million (2024), whereas its average is -$35.7 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Net Cash Flow crashed by 638.24% in 2021, and later skyrocketed by 4,594.74% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Net Cash Flow (Quarterly) stood at $172.3 million in 2021, then soared by 132.44% to $400.5 million in 2022, then plummeted by 93.66% to $25.4 million in 2023, then plummeted by 300.00% to -$50.8 million in 2024, then plummeted by 125.29% to -$21.6 million in 2025.
  • Its Net Cash Flow stands at -$21.6 million for Q3 2025, versus $117.2 million for Q2 2025 and $47.9 million for Q1 2025.